Wed. Oct 5th, 2022
Zydus Healthcare launches generic anti-diabetic Dapagliflozin tablets in India “In keeping with its efforts to make therapies accessible and affordable to patients, the drug will be highly economical, priced at 1/3rd the cost than currently available Dapagliflozin brands in India,” it added.